Maria Bedoya-Toro Insider Profile
11 Followers
Maria Bedoya-Toro, SVP, Regulatory Affairs at Dermata Therapeutics, holds 1.05K shares in Dermata Therapeutics (Ticker: DRMA), holds 0.00 shares in Santarus (Ticker: SNTS). Most recently, Maria Bedoya-Toro Bought ― shares of Dermata Therapeutics on Mar 17, 2026 for an estimated value of $1.27K.
Maria Bedoya-Toro has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Maria Bedoya-Toro's holdings
Insider Roles
SVP, Regulatory Affairs
Roles that Maria Bedoya-Toro holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Maria Bedoya-Toro
Maria Bedoya-Toro's Trading History
Dermata Therapeutics
Mar 17, 2026
SVP, Regulatory Affairs
Informative Buy
1.27K
$1.18K
Santarus
Jan 06, 2014
―
Uninformative Buy
288.71K
―
List of latest transactions for each holding click on a transaction to see Maria Bedoya-Toro's performance on stock
You May Also Like
Maria Bedoya-Toro insider profile FAQ
What is the percentage of profitable transactions made by Maria Bedoya-Toro?
The percentage of profitable transactions made by Maria Bedoya-Toro is ―.
What is the average return per transaction made by Maria Bedoya-Toro?
The average return per transaction made by Maria Bedoya-Toro is ―.
What stocks does Maria Bedoya-Toro hold?
Maria Bedoya-Toro holds: DRMA, SNTS stocks.
What was Maria Bedoya-Toro’s latest transaction?
Maria Bedoya-Toro latest transaction was an Informative Buy of $1.27K.
What was Maria Bedoya-Toro's most profitable transaction?
Maria Bedoya-Toro’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Maria Bedoya-Toro's role in Dermata Therapeutics?
Maria Bedoya-Toro's role in Dermata Therapeutics is SVP, Regulatory Affairs.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.